Nuvation Bio Inc (NUVB)
2.655
-0.02
(-0.93%)
USD |
NYSE |
Apr 24, 16:00
2.655
0.00 (0.00%)
After-Hours: 18:06
Nuvation Bio Cash from Operations (TTM): -68.00M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -68.00M |
September 30, 2023 | -69.14M |
June 30, 2023 | -81.08M |
March 31, 2023 | -90.51M |
December 31, 2022 | -96.11M |
September 30, 2022 | -103.42M |
June 30, 2022 | -88.48M |
Date | Value |
---|---|
March 31, 2022 | -78.39M |
December 31, 2021 | -68.19M |
September 30, 2021 | -57.64M |
June 30, 2021 | -52.54M |
March 31, 2021 | -42.54M |
December 31, 2020 | -36.53M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-103.42M
Minimum
Sep 2022
-36.53M
Maximum
Dec 2020
-71.74M
Average
-69.14M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
iBio Inc | -18.89M |
Flora Growth Corp | -8.396M |
Lixte Biotechnology Holdings Inc | -4.293M |
Replimune Group Inc | -172.10M |
ABVC BioPharma Inc | -4.236M |